MedPath

Global Management of Facial Rejuvenation With a New Range of Hyaluronic Acid Dermal Fillers

Not Applicable
Completed
Conditions
Facial Wrinkles
Interventions
Device: hyaluronic acid dermal fillers
Registration Number
NCT01151436
Lead Sponsor
Galderma R&D
Brief Summary

The aim of this study is to assess performance and tolerance as well as investigator and subject satisfaction linked to the global management of facial rejuvenation with a new range of hyaluronic acid dermal fillers.

Detailed Description

The range of fillers tested in this study includes 5 different hyaluronic acid dermal fillers: Emervel Touch, Emervel Classic, Emervel Deep, Emervel Volume and Emervel Lips.

The study will last 6 month.

Injections will be performed at baseline. If necessary, the investigator will perform touch-up injections at the following visit (3 weeks later).

Investigator and subject satisfaction will be collected through questionnaires.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
77
Inclusion Criteria
  • Seeking tissue augmentation treatment on the face,
  • Presenting a score of 3 (Moderately deep wrinkle)or 4 (Deep wrinkle) on the Lemperle Rating Scale (LRS) of both nasolabial folds.
Exclusion Criteria
  • At risk in term of precautions, warnings and contra-indication referred in the package insert of the study devices,
  • Who underwent previous injection of permanent filler in the injected area.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
hyaluronic acidhyaluronic acid dermal fillers-
Primary Outcome Measures
NameTimeMethod
Full Face Global Aesthetic Improvement6 months after last injection

Global aesthetic improvement scale score from baseline:

-1: worse 0: no change

1. improved

2. much improved

3. very much improved

Secondary Outcome Measures
NameTimeMethod
PERIORBITAL LINES SEVERITY ASSESSMENT6 MONTHS AFTER LAST INJECTION

Severity scored on Lemperle Rating Scale:

0: no wrinkles

1. just perceptible wrinkle

2. shallow wrinkle

3. moderately deep wrinkle

4. deep wrinkle, well-defined edges

5. very deep wrinkle redundant fold

CHEEK FOLDS SEVERITY ASSESSMENT6 MONTHS AFTER LAST INJECTION

Severity scored on Lemperle Rating Scale:

0: no wrinkles

1. just perceptible wrinkle

2. shallow wrinkle

3. moderately deep wrinkle

4. deep wrinkle, well-defined edges

5. very deep wrinkle redundant fold

NASOLABIAL FOLDS SEVERITY ASSESSMENT6 months after last injection

Severity scored on Lemperle Rating Scale:

0: no wrinkles

1. just perceptible wrinkle

2. shallow wrinkle

3. moderately deep wrinkle

4. deep wrinkle, well-defined edges

5. very deep wrinkle redundant fold

UPPER LIP LINES SEVERITY ASSESSMENT6 MONTHS AFTER LAST INJECTION

Severity scored on Lemperle Rating Scale:

0: no wrinkles

1. just perceptible wrinkle

2. shallow wrinkle

3. moderately deep wrinkle

4. deep wrinkle, well-defined edges

5. very deep wrinkle redundant fold

MARIONETTE LINES SEVERITY ASSESSMENT6 MONTHS AFTER LAST INJECTION

Severity scored on Lemperle Rating Scale:

0: no wrinkles

1. just perceptible wrinkle

2. shallow wrinkle

3. moderately deep wrinkle

4. deep wrinkle, well-defined edges

5. very deep wrinkle redundant fold

LIP ENHANCEMENT ASSESSMENT6 MONTHS AFTER LAST INJECTION

Lip fullness grading scale score:

0: very thin lip

1. thin lip

2. moderately thick lip

3. thick lip

4. full lip

Trial Locations

Locations (1)

Galderma investigational site

🇩🇪

Darmstadt, Germany

© Copyright 2025. All Rights Reserved by MedPath